BIOMEDevice

Date: April 22, 2009, 7:00am - April 23, 2009, 7:00pm
Location: Boston, MA

Embrace Change Strategically: Mitigate Risks and Leverage the Value of Convergence

Join us at the BIOMEDevice Forum to stay ahead of the trends and navigate change in the current economic climate. Don't miss the opportunity to examine how the credit crisis and volatile markets have affected cross-sector collaborations within the life sciences and hear what steps leaders in the industry are taking to address these challenges.

In addition to providing valuable insight into the risks and benefits associated with convergent medical technologies, this two-day forum offers the opportunity to exchange ideas and share strategies with your peers in a face-to-face format. More than one hundred of your colleagues have already registered for the forum, register now while space is still available.

BIOMEDevice Forum Agenda Highlight:

Risk Management for Convergent Medical Technologies

The Riegel v. Medtronic Supreme Court decision rocked the world of medical product liability. What are the implications of this decision for combination products and how should life science companies manage their product liability risks? Which companies will benefit and which companies won't from the Riegel decision? What risk management tactics become more or less important in light of Federal preemption? A panel comprised of a medical device company representative, a defense attorney, and a risk management specialist will offer insights and tips that attendees can use to lower costs and broaden their companies' financial protection.

Moderator
Kevin Quinley, CPCU, Principal, Quinley & Associates

Panelists
Joseph Leghorn, Partner, Nixon Peabody
Timothy Pratt, EVP, Secretary & General Counsel, Boston Scientific Corporation

Contact June Portnoy to register for the forum at 215-944-9819 or e-mail june.portnoy@cancom.com.